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NALOXONE - DOES OVER-ANTAGONISM MATTER? EVIDENCE OF 
IATROGENIC HARM AFTER EMERGENCY TREATMENT OF HEROIN/OPIOID 
OVERDOSE 
 
 
ABSTRACT 
 
Aim To analyze drug users’ views and experiences of naloxone during emergency 
resuscitation after illicit opiate overdose in order to identify i. any evidence of harm caused 
by excessive naloxone dosing (‘over-antagonism’); ii. implications for the medical 
administration of naloxone within contemporary emergency settings.   
Design Re-analysis of a large qualitative dataset (interviews and non-participant observation) 
generated between 1997 and 1999. 
Setting Emergency departments, drug services and pharmacies in two Scottish cities.  
Participants 200 illicit opiate users: 131 males; 69 females. 
Findings Participants had limited knowledge of naloxone and its pharmacology, yet routinely 
described it in negative terms and were critical of its medical administration. In particular, 
they complained that naloxone induced acute withdrawal symptoms, causing patients to 
refuse treatment, become aggressive, discharge themselves from hospital, and take additional 
street drugs to counter the naloxone effects. Participants believed that hospital staff should 
administer naloxone selectively and cautiously and prescribe counter-naloxone medication if 
dosing precipitated withdrawals. In contrast, observational data indicated that participants did 
not always know that they had received naloxone and hospital doctors did not necessarily 
administer it incautiously. 
Conclusions Opiate users repeatedly reported harm caused by naloxone over-antagonism. 
Good treatment in emergency settings involves building and sustaining trust with patients and 
those who accompany them. Protocols are needed for titrating naloxone dose against 
response to prevent sudden acute withdrawal syndrome, with attendant risks of self-
discharge, further drug use and even death. The concept of contemporary legend helps to 
explain why naloxone had such a poor reputation amongst opiate users.  
 
Key words: qualitative study, naloxone, overdose, opiates, contemporary legend 
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NALOXONE - DOES OVER-ANTAGONISM MATTER? EVIDENCE OF 
IATROGENIC HARM AFTER EMERGENCY TREATMENT OF HEROIN/OPIOID 
OVERDOSE 
 
 
INTRODUCTION 
 
Naloxone saves lives when given by emergency medical staff in accident and emergency 
departments and by ambulance personnel attending overdoses in the community.1-3 Over the 
last decade, naloxone distribution programmes have been introduced, as public health 
initiatives and individual health treatments, to prevent heroin/opioid overdose deaths,4-17 
Programmes involve the supply of naloxone (plus training in wider overdose management) to 
drug users and to their families, enabling interim emergency care while awaiting the arrival 
of an ambulance.18 19 
 
NHS England recently issued a Patient Safety Alert (NHS/PSA/W/2014/016; 20 November 
2014) on ‘Risk of distress and death from inappropriate doses of naloxone in patients on 
long-term opioid or opiate treatment’. This alert primarily addressed risk in relation to the 
treatment of pain in older people, but warned that: “Use of naloxone in patients where it is 
not indicated, or in larger than recommended doses, can cause a rapid reversal of the 
physiological effects for pain control, leading to intense pain and distress, and an increase in 
sympathetic nervous stimulation and cytokine release precipitating an acute withdrawal 
syndrome.” Amongst dependent opiate users who have overdosed, naloxone can also cause 
sudden-onset acute withdrawal syndrome with evidence of aggression20 and medical self-
discharge.21 22  
 
Since patient safety is uncertain when hospital admission does not occur after naloxone 
administration for acute opioid toxicity23, clinical algorithms to support discharge decision-
making have been developed.24-27 Dose and route are not, however, agreed, with quantities 
given ranging from 0.4mg3 27 to 2mg or more.1 Several studies have found no evidence of 
deaths after self-discharge24 27-30, but weaknesses in these studies have been identified.27 
Furthermore, a recent European analysis reported a small incidence of post-naloxone 
mortality (3/2241; 0.13%) which was attributed to ‘rebound opioid toxicity’.22 The clinician 
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is thus ‘walking a prescribing tightrope’3 between adequate resuscitation and precipitation of 
acute withdrawals with attendant risks of self-discharge and subsequent harm. 
 
Better understanding of opiate users’ views and experience of emergency naloxone is needed 
to support medical care and decision-making, and to inform the wider pre-supply of 
naloxone, as recently advocated by World Health Organization, United Nations and others.16 
31 32 In the absence of any current or recent research exploring this issue, we have returned to 
an earlier ethnographic study of non-fatal overdose to seek insights. In so doing, our aim is to 
analyze opiate users’ views and experiences of naloxone during emergency resuscitation in 
order to identify i. any evidence of harm caused by excessive naloxone dosing (‘over-
antagonism’) and ii. implications for the medical administration of naloxone within 
contemporary emergency settings.   
 
 
METHOD 
 
The study was undertaken between 1997 and 1999 and the lead researcher (JN) is a current 
author. Findings relating to naloxone were discussed briefly in a publication written at the 
time and included cautionary warnings that opiate users tended to hold very negative views of 
the antagonist, believed that it could induce painful withdrawal symptoms, and were anxious 
that it might be administered to them.33 Despite this, no detailed analyses of naloxone were 
undertaken.  
 
Fieldwork occurred in two Scottish cities known for their high levels of illicit drug overdose. 
Qualitative interviews were conducted with 200 opiate users, over a third of whom were 
interviewed and observed in the emergency department or acute hospital ward within a few 
hours of an overdose occurring. Individuals were recruited in two groups. Group A 
participants (n=77) were purposively sampled through six hospital emergency departments. 
Group B participants (n=123) were opportunistically sampled through drug agencies, 
pharmacies providing services to drug users and snowballing.  
 
All 200 participants were current users of heroin, methadone and/ or dihydrocodeine, but 
other types of drug taking were common. In total, 153/200 (77%) had ever personally 
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overdosed: 76 (99%) group A participants and 77 (63%) group B participants. Further 
demographic information is provided in Table 1. Ethical approval was granted from six NHS 
research ethics committees; details previously reported.34 
 
INSERT TABLE 1 
 
Group A interviews were conducted at all hours of the day and night, most frequently 
between 9pm and 1am. Hospital staff telephoned the researcher whenever an individual 
arrived in the emergency department with symptoms of illicit drug overdose. The researcher 
was available 24/7 for thirteen months. Seventy interviews were conducted in the 6 hospitals 
and 7 took place later, in the drug user’s home or local drug service. Group B interviews all 
occurred during the day or early evening and were conducted in drug agencies, cafes, public 
houses, shopping malls and the researcher’s car. 
 
Interviews lasted 20-90 minutes, were audio recorded and transcribed verbatim. The 
interview schedule covered: biographical details; current and past drug use; participation in 
treatment; overdoses experienced; overdoses witnessed; general opinions about overdose; 
and additional comments. The same core topics were introduced in each interview, but 
participants were encouraged to reflect on and discuss issues that were most relevant to them 
personally. Although 47 participants had never personally overdosed, nearly all had 
witnessed an overdose and everyone had views on overdosing.  
 
Transcribed interview data and fieldnotes were indexed at the time of the study using the 
software package WinmaxPro (now MAXQDA) and analysed using ‘Framework’.35 For the 
present analyses, all data previously indexed to a broad generic code ‘naloxone’ were 
exported to a single Microsoft Word document for re-analysis, again using the principles of 
Framework. First, JN reviewed the naloxone Word file line-by-line, systematically ordering 
the findings under emergent headings. Both authors then reviewed, discussed and revised the 
ordered data, creating six inter-linked core themes (see Findings below). JN next returned to 
the coded data to check the core themes for internal validity, to map the range and nature of 
data under each core theme, and to explore any differences between sub-groups of 
participants. Lastly, both authors interpreted the findings with reference to naloxone 
administration, identifying the concept of contemporary legend as a useful explanatory 
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heuristic.   
 
In our reporting, we have used non-specific forms of semi-quantification (‘many’, ‘several’, 
‘a few’) to convey general patterns within the data, reserving raw numbers and more precise 
quantitative terms only for those occasions when findings could be reliably quantified.36 
Differences between sub-groups of participants are recorded where identified. As with any 
qualitative research, empirical findings cannot be generalizable beyond the study population. 
 
 
FINDINGS 
 
 
(i) General knowledge of naloxone 
 
Approximately a third of all participants (from groups A and B) had not heard of naloxone 
(or its street names) and did not recognize it from the researcher’s description of when, how 
and why it was used. Several participants (again from both groups) said that they were aware 
of the drug but then appeared to confuse it with amphetamine sulphate (‘speed’). Others, who 
had seen intracardiac injection scenes in popular films such as ‘Pulp Fiction’, wrongly 
believed that naloxone was adrenaline, administered violently via ‘a large needle’ into the 
hearts of overdose victims. 
 
Fieldnote: Barry asks the doctor about the needle that was put into his heart last time 
he was in the emergency department. The doctor says that this was unlikely and Barry 
must be confused. [Barry, 29 years, group A] 
 
Few participants knew naloxone by its generic or trade name, Narcan. However, nearly all 
recognized it when the researcher used street terms, such as ‘the jag’, ‘adrenaline’, or ‘the 
reverse’, or when she provided more detail on its use. Whilst injectors and participants who 
had friends or relatives who were also opiate users seemed more likely to have heard of 
naloxone than other study participants, there was no discernible pattern of knowledge relating 
to whether or not someone had personally had an overdose or ever injected. 
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Participants who had heard of naloxone mostly had very limited knowledge of its 
pharmacology; essentially, they knew that it rapidly reversed the effects of a heroin overdose 
in an emergency situation. Several individuals volunteered further details. For example, a few 
reported that the antidote ‘dulled’ the effects of any illicit drugs subsequently taken, so 
increasing an individual’s propensity to overdose if they used street drugs post 
administration. Three commented that the amount of naloxone administered to an overdose 
victim should depend on the quantity of heroin and other drugs taken and one also 
emphasized that the consequences of getting this wrong could be very dangerous.  
 
I can’t imagine what it would be like if they [hospital staff] injected Narcan on a 
small dose of heroin and put you into withdrawal. The psychological effects of that 
must be terrible... I could see people committing suicide. [Adam, 28 years, group A] 
 
 
(ii) Personal experiences of naloxone  
 
It was not possible to ascertain the actual number of participants who had ever received 
naloxone, since many did not know what naloxone was. Nonetheless, 74 (47 men; 27 
women) believed they had been treated with naloxone at some point in their lives (some on 
many occasions). Individuals who stated that they had personally had naloxone frequently 
complained that it had made them feel ‘horrible’ or very unwell, and had induced acute opiate 
withdrawal symptoms, such as shaking, headaches, and vomiting, sometimes lasting several 
days.  
 
They gave me that injection, that, er, reverse, and I woke up absolutely shaking… It 
was like instant withdrawals. It was the most horrendous experience that I've ever 
been through. [Beverley, 33 years, group A] 
 
Hellish… I was in my bed for about three days after it. [I] couldn’t move, being sick… 
I was really ill. Cramps, everything. [Francis, 22 years, group B] 
 
These naloxone-induced withdrawal symptoms were sometimes so severe that participants 
reported going ‘mad’ or ‘crazy’ or losing their temper and becoming aggressive or violent 
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with hospital staff, particularly if they had explicitly requested not to be treated with the 
antidote. 
 
I said to them [hospital staff], ‘Please don’t give me adrenaline’. And he [doctor] 
said ‘No, I’m not going to give you adrenaline’. [And he] stuck the needle in my arm. 
And I knew because I felt the tingling in my foot. And that’s when I went crazy… 
Grabbed the metal side of the bed and I was kicking it and screaming and pulling my 
hair out. [Rab, 25 years, group B]  
 
 
(iii) Personal responses when offered naloxone  
 
Prior negative experiences of naloxone seemed especially relevant when considering group A 
participants’ reactions to naloxone at the point of their current overdose. Few willingly 
accepted naloxone if they were conscious. Most refused the drug or reported that they would 
have refused it if they had been offered it. Indeed, many did their utmost to avoid naloxone 
by, for example, discharging themselves from hospital whilst waiting for a doctor to arrive or 
trying to force themselves to stay conscious and alert when nurses were around.  
 
Fieldnote: At about 11pm the doctor arrived and suggested Narcan. Mary reacted 
very negatively and threatened to leave… Mary washed her face in the sink and tried 
to revive herself. The nurse returned and Mary refused the Narcan but agreed to wait 
for the blood test results. [Mary, 22 years, group A] 
 
In practice, group A participants had sometimes been given naloxone whilst unconscious or 
too ill to be able to refuse treatment. Moreover, some had been given multiple doses over 
several hours. These individuals often reported that they had not been given naloxone, even 
though friends or relatives present, hospital staff, hospital notes, or the researcher’s own 
observations indicated otherwise. In none of these situations, did the researcher record any 
evidence of withdrawal symptoms and the participants themselves did not report any. On the 
contrary, several stated that they were starting to feel better since arriving at the hospital and 
receiving treatment.  
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Fieldnote: Majorie cannot remember having a naloxone injection, although the 
hospital staff said that she had… 
Participant: They were going to give me Narcan, but I didn’t want it. I started 
screaming. 
Researcher: So you didn’t get any? 
Participant: No… I would have marks on me if I had, because they’d have had to get 
a vein… If I’d had narcan, I’d have been shivering now. I’ve not had it. [Marjorie, 28 
years, group A] 
 
 
(iv) Further drug use to counter the effects of the naloxone 
 
Thinking back to their previous overdoses, four participants (2 from group A; 2 from group 
B) described how, after being treated with naloxone, they had discharged themselves from 
hospital because they felt that they needed to take more street drugs to offset the withdrawals. 
As they neither had drugs nor money with them in the hospital, this meant that they had first 
had to obtain money and then find a dealer.  
 
I just bolted. Signed myself out [of hospital]. I came home… got a loan of a tenner 
[£10] off somebody… and I just went out and got another one [deal of heroin]. 
[Willy, 29 years, group B] 
 
One participant (group A) had also consumed a considerable amount of alcohol and then 
gone to a local drug treatment service for help. Another reported that he had broken into a 
drug dealer’s house and robbed him. Two group B participants also reported that their 
withdrawal symptoms had been so severe that hospital staff had prescribed them methadone 
or lofexidine to counter the naloxone they had been given. One of these had then 
supplemented this with methadone he had stored at home. Several participants also stated that 
concern about having to take more drugs to counter any naloxone received was a major factor 
in their refusal of the treatment. 
 
Researcher: If someone offered you that [naloxone] again, would you take it? 
Participant: No definitely not. 
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Researcher: Why not? 
Participant: Because it’s instant withdrawals and then when I go out of here 
[hospital], the first thing I would do is look for something else to take that pain away. 
[Beverley, 33 years, group A] 
 
 
(v) General views of naloxone 
 
Almost all participants who had heard of naloxone described it in very negative terms, 
emphasizing how it should be avoided since it caused instant and unpleasant withdrawal 
symptoms: it ‘takes your stone away’, ‘strings you out’, ‘makes you rattle’, ‘is instant 
hangout’, ‘makes you feel sick’, ‘causes a headache’, ‘ruins the hit’, and ‘makes you feel 
worse’. Indeed, so pervasive was the belief that naloxone inevitably caused withdrawal 
symptoms that one person whose friend had been treated for an overdose and yet not 
experienced withdrawal symptoms believed that the friend must have been given a different 
treatment, not naloxone. 
 
They've got a new one [drug] out now that makes you feel alright. You don’t feel 
strung out when you take it… Somebody I was in hospital with got it, and he thought 
he was going to be strung out…, and he says he was fine after it. [Benjamin, 25 years, 
group B]  
 
Supporting their own views, participants often described the adverse reactions of their 
friends, relatives, and acquaintances (sometimes witnessed first-hand and sometimes based 
on second-hand or third-hand accounts). Thus they spoke of other drug users also refusing to 
go to hospital, ‘climbing out of the back of ambulances’, ‘signing themselves out of 
hospitals’, and being in withdrawal for several days post naloxone administration. One 
participant even described how a friend had left hospital, taken more drugs, and then died.  
 
Elaborating further on their dislike of naloxone, participants sometimes argued that drug 
users want to be ‘stoned not sober’ and ‘prefer to sleep opiates off rather than be 
resuscitated’. Consequently, those who overdosed might not be grateful for any medical 
intervention. On the contrary, they might be angry as treatment with naloxone would mean 
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that they had effectively ‘wasted their money’ and would now need to go out and commit 
more crime in order to get drugs.  
 
Anybody waking up and being totally right into withdrawals would be angry. And the 
possibility is they've spent all their money and they've not got money to get anything 
else. [Suzanne, 31 years, group B] 
 
Despite these very negative views, some participants still thought that naloxone should be 
administered to overdose patients contrary to their wishes as it was necessary to save their 
lives. Equally, several argued that naloxone was a ‘good thing’ or a ‘good idea’. These 
included a small number of individuals who had never heard of naloxone until the researcher 
described it to them in the interview and also a few participants (from both groups A and B) 
who had previously been treated with the antidote and had subsequently felt better.  
 
I think it’s a good idea. Because anybody that’s overdosed, they’re still alive… I felt 
brand new after it [naloxone injection]. I just felt normal. [Drew, 32 years, group B] 
 
 
(vi) Opinions on medical practice 
 
In total, seven participants (from groups A and B) gave angry accounts of opiate users 
(themselves or others) regaining consciousness and finding paramedics or hospital staff 
standing over them about to inject naloxone. Medics had then attempted to proceed with the 
injection contrary to the patient’s wishes, resulting in disagreements and physical struggles.  
 
Because they gave me something in the ambulance, but they were holding me down 
because I didn’t want them to put it in my arm. [Patrick, 27 years, group A] 
 
Two group A participants were annoyed that hospital staff had told them that they had not 
had the antidote, when they strongly believed that they had had it. Additionally, another 
group A participant criticized hospital staff for trying to give her naloxone without telling her 
enough about the drug and its side effects. One group B male further complained that he had 
been given naloxone as a punishment and to deter him from using heroin in the future. 
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Participants’ accounts indicated that these negative experiences undermined patient trust in 
medical practice, so increasing the potential for hostility and violence. 
 
When I got that adrenalin… I was up to the hospital two days in a row with a tin of 
CS gas and a butterfly knife… I was going to stab the doctor for doing that to me. I 
was coming out of it [the overdose], waking up...  I know the only reason they did it 
was to put me off heroin. [Dougie, 27 years, group B] 
 
Consistent with their generally negative views of naloxone, several participants stated that the 
drug should be given more cautiously and selectively; not against a patient’s wishes and 
certainly not if the patient was already conscious. Others argued that hospital staff should 
dispense methadone or other medication to counter naloxone-induced withdrawals, thus 
lessening the likelihood that patients would be anxious and refuse to be admitted to hospital. 
Interestingly, no participant reported that medics might ever consider but then decide not to 
administer naloxone. Yet, the researcher recorded several instances of doctors being unsure 
that the patient had actually taken opiates and so concluding that naloxone was inappropriate 
or deciding that it would be better for the patient to sleep their drugs off on the ward.  
 
Notwithstanding a general hostility to medical practitioners, a small number of participants 
from both groups A and B maintained that paramedics and hospital staff were only trying to 
help overdose patients by administering naloxone and so it was unfair to be angry with them. 
In addition, one participant recounted a recent positive experience of being at the hospital 
with a friend who had overdosed. The friend had not wanted naloxone because he did not 
want to experience withdrawal symptoms overnight in hospital. However, a nurse had taken 
time to explain that that would not happen. The friend had then accepted the naloxone and 
recovered well.  
 
 
DISCUSSION 
 
Opiate users repeatedly reported harm caused by naloxone over-antagonism. Naloxone was 
perceived very negatively by the study participants who emphasized its adverse effects, 
including acute withdrawal symptoms with associated aggression towards hospital staff, 
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refusal of treatment, premature self-discharge from medical care, and the need to obtain and 
take further illicit drugs. These critical views derived from their first-hand experiences and 
second-hand and third-hand accounts. Paralleling their reports of naloxone’s harmful effects, 
participants additionally provided descriptions (self-report and anecdotal) of poor treatment 
by medical staff, including suggestions that naloxone was administered unnecessarily, in 
excess of that required, and even as a deterrent to (and possible punishment for) continued 
drug use. 
 
Negative views of naloxone and accounts of harm caused by its administration were not, 
however, universal and were notably absent from the observational data. This discordance 
can be examined in conjunction with participants’ lack of knowledge and confusion about 
naloxone; for example, Barry’s seemingly mistaken belief that he had had the emergency 
drug injected directly into his heart and participants’ certitude that they had not received 
naloxone when administration had been observed by the researcher or reported by others 
present. This is not to suggest that participants deliberately falsified their accounts. We are 
simply reminded that personal belief and testimony may not always coincide with reality 
(‘veridicality’).37 ‘Antagonistic’ administrations of naloxone clearly occurred; yet, naloxone 
also saved lives and its administration did not inevitably cause harm or generate patient 
distress.  
 
Before turning to the practical implications of our analyses, it is important to try to 
understand why naloxone had such a poor reputation amongst these Scottish opiate users. The 
concept of contemporary legend is not perfect, but offers a useful heuristic for explaining the 
findings. Contemporary legends constitute a form of folklore that can be based on fact, tend 
to be spread by word of mouth, and are often believed to be true by the tellers.38-42 They are 
flexible narratives that provide individuals with a means of communicating and negotiating 
genuine fears and unexplained experiences.39 43 For our interviewees, accounts of antagonistic 
naloxone administration appeared to facilitate the expression of legitimate anxieties about 
overdosing, poor medical treatment, stigmatizing attitudes, painful withdrawal symptoms, 
and the difficulties of drug procurement. In a context where knowledge of naloxone was poor 
and mistrust between drug users and hospital staff already existed33, few 'antagonistic' 
administrations would be necessary to create a ‘received wisdom’ of hostile intent that 
fuelled negative expectations.  
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Our analyses were based on 70 face-to-face interviews conducted within a few hours of 
heroin/opioid overdose occurring, supplemented by observations from hospital settings and a 
further 130 interviews. Although participants were recruited from only two cities in Scotland, 
their gender and age profile was broadly similar to that identified in other national and 
international studies of drug overdose at the time.44-46 Sampling was purposive (group A) and 
opportunistic (group B), rather than sequential or randomized. Nonetheless, the study 
captured a substantial number of overdose resuscitations in the two localities over the study 
period. No individual approached within any emergency department refused to participate, 
and so no selection bias occurred on the part of the overdose victims themselves. In support 
of our findings, opiate users’ misconceptions about naloxone and negative views of its impact 
and use have also since been reported in another smaller qualitative study conducted in the 
US.47  
 
Ultimately, however, our data were collected in 1998/9 and the relevance of our findings to 
contemporary emergency care needs to be considered carefully. Today, the acceptability and 
uptake of naloxone have increased significantly, as evidenced by the widespread introduction 
of naloxone programmes, including peer driven and community-based programmes.48 Indeed, 
there is a certain irony that the data we present are from Scotland, where the world’s first 
national naloxone programme was later launched. Despite this, we cannot assume that 
positive perceptions and more sensitive administrations of the antagonist exist everywhere 
and amongst all stakeholders, particularly given that naloxone programmes are only now 
emerging in most of the world.16 32 Accordingly, we believe that themes evident in our data, 
and the explanatory concept of contemporary legend, still have important implications for 
contemporary emergency practice.  
 
Crucially, our findings attest to the power of belief and folklore over lived experience, 
reminding us that instances of negative medical events (however rare or unlikely) can have a 
disproportionately harmful impact when they do occur. In addition to painful withdrawal 
symptoms, over-antagonism can result in reputational damage to the emergency services and 
their resuscitation efforts, such that individuals may discharge themselves prematurely or 
even refuse to consent to treatment. Thus, naloxone is transformed from a life-saving 
medication delivered by caring practitioners into a painful and withdrawal-precipitating 
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punishment administered by a hostile workforce. This is exacerbated by poor knowledge and 
understanding of naloxone amongst opiate users, insensitive and coercive medical 
administrations, lack of communication about the antagonist at the point of treatment, and 
pre-existing mistrust between drug users and medical staff.  
 
In response, we suggest that it is incumbent on those working in emergency settings to look 
beyond the immediate resuscitative value of naloxone. Good treatment involves building and 
sustaining trust with patients and those who accompany them, providing clear information on 
how the antagonist works and its potential side effects, and being sensitive to patients’ likely 
and understandable fears and concerns. In addition, more attention needs to be paid to 
protocols for titrating naloxone dose against response in order to prevent sudden acute 
withdrawal syndrome, with the attendant risks of self-discharge, further drug use and even 
death. As previous commentators have observed9 27, the research literature is disappointingly 
weak on the dose-response relationship and the influence of individual variability. Until this 
knowledge gap is addressed, clinicians should seek to reverse life-threatening respiratory 
depression without clearing the opiate receptors so comprehensively that full-blown opiate 
withdrawal syndrome is precipitated.  
 
The timely emergency administration of naloxone to an unconscious heroin/opiate overdose 
victim can unquestionably be good medical practice. However, providing this life-saving 
intervention in a way that triggers post-resuscitation distress and suffering can diminish its 
benefit, damage its reputation, and undermine patient/doctor trust. Medical decisions made 
about individual opiate overdose patients today can influence the future behavior of those 
same individuals, but also the behaviour of others within their wider networks.  In this regard, 
it does not matter whether circulating accounts of naloxone are right, wrong, or an 
exaggeration of the truth. The concept of contemporary legend facilitates understanding of 
the genesis of community beliefs and how they can influence help-seeking, consent to 
treatment, interactions between drug users and medical staff, risk of rebound toxicity19 and 
compound overdose. Importantly, though, the telling and re-telling of horror stories about 
naloxone and its administration are not inevitable. Contemporary legends are dynamic and 
open to revision. Competent care and user participation in new naloxone training 
programmes, such as those recently introduced in Scotland17 49 50, provide valuable 
opportunities for, and have already demonstrated some success in, changing harmful legends. 
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TABLE 1: PARTICIPANT DETAILS   
 
Demographic 
characteristics 
Group A 
n = 77 
Group B 
N = 123 
All 
n = 200 
Gender    
   Male 54 (70%) 77 (63%) 131 (66%) 
   Female 23 (30%) 46 (37%) 69 (35%) 
Mean age (years) 27 (range 15-47) 28 (range 17-45) 28 (range 15-47) 
Mean age of first use 
(years) 
16 (range 5-32) 16 (range 7-32) 16 (range 5-32) 
Mean years of use 11 (range 1-27) 12 (range 1-31) 12 (range 1-31) 
Ever overdosed    
   Yes 76 (99%) 77 (63%) 153 (77%) 
   No 1 (1%)* 46 (37%) 47 (24%) 
Ever injected**    
  Yes 58 (75%) 94 (76%) 152 (76%) 
  No 18 (23%) 29 (24%) 48 (24%) 
Ever used heroin    
   Yes 61 (79%) 99 (81%) 160 (80%) 
   No 16 (21%) 24 (20%) 40 (20%) 
* One male was interviewed in the emergency department after cutting his wrists. He had 
witnessed overdoses but never personally had an overdose 
** Missing = 1 
 
